Evidence map›Paper›PMID 24035345›Full record

Observational studyBiological psychiatry2014

Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy.

Diana Martinez, Mark Slifstein, Nabeel Nabulsi, Alexander Grassetti, Nina B L Urban, Audrey Perez, Fei Liu, Shu-Fei Lin, Jim Ropchan, Xiangling Mao and 4 more

Abstract readObservational Study
In one paragraph

Observational study in Biological psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 3 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Quantification of [Current neuropharmacology · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Higher striatal glutamate in male youth with internet gaming disorder.European archives of psychiatry and clinical neuroscience · 2024
    Article
  13. Article
  14. Testing PET-[Imaging neuroscience (Cambridge, Mass.) · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Preclinical evidence to support repurposing everolimus for craving reduction during protracted drug withdrawal.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Diana MartinezDepartment of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York. Electronic address: dm437@columbia.edu.
Mark SlifsteinDepartment of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York.
Nabeel NabulsiDepartment of Psychiatry, Yale Positron Emission Tomography Center, Yale University School of Medicine, New Haven, Connecticut.
Alexander GrassettiDepartment of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York.
Nina B L UrbanDepartment of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York.
Audrey PerezDepartment of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York.
Fei LiuDepartment of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York.
Shu-Fei LinDepartment of Psychiatry, Yale Positron Emission Tomography Center, Yale University School of Medicine, New Haven, Connecticut.
Jim RopchanDepartment of Psychiatry, Yale Positron Emission Tomography Center, Yale University School of Medicine, New Haven, Connecticut.
Xiangling MaoDepartment of Radiology, Weill Medical College of Cornell University, New York, New York.
Lawrence S KegelesDepartment of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute, New York, New York.
Dikoma C ShunguDepartment of Radiology, Weill Medical College of Cornell University, New York, New York.
Richard E CarsonDepartment of Psychiatry, Yale Positron Emission Tomography Center, Yale University School of Medicine, New Haven, Connecticut.
Yiyun HuangDepartment of Psychiatry, Yale Positron Emission Tomography Center, Yale University School of Medicine, New Haven, Connecticut.
Yale University · USNew York State Psychiatric InstituteColumbia University · USCornell University · US

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Using PET to Image the Neurochemistry of AddictionK02DA026525 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARTINEZ, DIANA M · 2009 to 2018
$1.3M
PET imaging of the mGluR5 in cocaine abuseRC1DA028033 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MARTINEZ, DIANA M · 2009 to 2010
$761k
NCRR NIH HHS UL1 RR024139NIDA NIH HHS K02 DA026525NIDA NIH HHS RC1 DA028033
6 · The paper itself

Abstract

backgroundPreclinical studies demonstrate that glutamate homeostasis in the striatum is disrupted following cocaine exposure, including a decrease in metabotropic glutamate receptor type 5 (mGluR5) expression and reduced glutamate turnover. The goal of this study was to use imaging of the human brain to investigate alterations in the glutamate signaling in cocaine addiction.

methodsPositron emission tomography imaging with the radiotracer [(11)C]ABP688 was used to measure mGluR5 binding and magnetic resonance spectroscopy was used to measure glutamate-glutamine levels in the striatum of cocaine-addicted participants (n = 15) compared with healthy control subjects (n = 15). Following the scans, the cocaine-addicted volunteers performed cocaine self-administration sessions to investigate the correlation between cocaine-seeking behavior and mGluR5 receptor binding.

resultsThe results of the study showed that cocaine addiction was associated with a 20% to 22% reduction in [(11)C]ABP688 binding in the striatum. A secondary analysis of cortical and subcortical regions other than the striatum showed a similar reduction in [(11)C]ABP688 binding, suggesting that the decrease was widespread. No between-group differences were seen in the magnetic resonance spectroscopy measures of glutamate-glutamine in the left striatum. In addition, no correlation was seen between [(11)C]ABP688 binding in the striatum and the choice to self-administer cocaine.

conclusionsOverall, these results show that long-term cocaine use is associated with a decrease in mGluR5 availability compared with matched healthy control subjects and suggests that this receptor may serve as a viable target for treatment development for this disorder.

Indexed as

HomeostasisOximesPyridinesAdultBrainCarbon RadioisotopesCase-Control StudiesChoice BehaviorCocaineCocaine-Related DisordersCorpus StriatumFunctional NeuroimagingGlutamic AcidGlutamineHumansMagnetic Resonance Spectroscopy3-(6-methylpyridin-2-ylethynyl)cyclohex-2-enone-O-methyloximeCarbon RadioisotopesCocaineGlutamic AcidGlutamineOximesPyridinesReceptor, Metabotropic Glutamate 5Addictioncocainecocaine self-administrationmagnetic resonance spectroscopymetabotropic glutamate receptor 5positron emission tomography

Identifiers

PMID24035345
PMCPMC4106018
OpenAlexW2123699076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.